The Trump-Vance administration has the opportunity to take decisive action to curb the devastating effects of drug ...
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
With the FDA quietly rolling back DEI initiatives under Trump’s latest executive order, experts warn that underrepresentation ...
For more than a decade, the Food and Drug Administration (FDA) has made diversity in clinical trials a focus, including by issuing guidance, ...
The Trump administration told federal public health agencies like the CDC that they are not to communicate health messages for now. The hold includes memos, reports, online posts, website updates and ...